Tumor-Specific Differences, Genomic Alterations of Biliary Tract Cancers Identified
Gastrointestinal cancers have a diverse landscape of clinically relevant genomic alterations (CRGA) that could lead to targeted drug therapy.
GI Cancers Symposium 2015
eNOS Polymorphisms May Influence Prognosis in Hepatocellular Carcinoma Treated with Sorafenib
Endothelial nitric oxide synthase (eNOS) VNTR and eNOS -786 could determine outcomes in advanced hepatocellular carcinoma treated with sorafenib,
In Advanced Hepatocellular Carcinoma, Baseline AFP May Predict Response to Ramucirumab
Baseline α-fetoprotein (AFP) levels may be a predictive marker for advanced hepatocellular carcinoma receiving ramucirumab.
Similarities, Differences Between Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas
Comprehensive genomic profiling (CGP) shows promise in advanced esophageal squamous cell carcinomas (ESCC) and adenocarcinoma (EAC).
Hybrid Minimally Invasive Oesophagectomy Use for Oesophageal Cancer Supported
Hybrid minimally invasive oesophagectomy (HMIO) is associated with fewer complications for resectable oesphageal cancer.
Laproscopically Assisted Distal Gastrectomy Safe for Stage 1 Gastric Cancer
Laproscopically assisted distal gastrectomy (LADG) is safe for patients with clinical stage 1 gastric cancer.
Pembrolizumab Shows Antitumor Activity, Manageable Toxicity in Advanced Gastric Cancer
Pembrolizumab demonstrated promising antitumor activity and manageable toxicity in advanced gastric cancer.
For Gastroesophageal Adenocarcinoma, Addition of Onartuzumab to FOLFOX Does Not Improve Survival
Addition of onartuzumab to mFOLFOX6 for gastroesophageal adenocarcinoma (GEC) did not improve survival.
AMG-337 May Be Effective for MET-Amplified Gastrointestinal Tumors
AMG-337 caused responses in patients with MET-amplified gastroesophageal junction, gastric cancer, and esophageal cancer.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in GI Cancers Symposium 2015
Loading... 
Loading...